Meniere disease pipeline: Data Byte

Otonomy’s negative Phase III readout calls into question the utility of targeting the glucocorticoid receptor to treat Meniere disease. 

There are no approved drugs to treat the disorder, which is caused by the buildup of fluid in the inner ear, leading to episodes of vertigo. Other symptoms include tinnitus and hearing loss...